Invests about 0.5 bln pounds for additional stake (Il Sole 24 Ore Radiocor) - London , 27 Sep - Haleon, a UK provider of consumer healthcare products, said it has agreed to acquire an additional ...

Pfizer is unloading a significant part of its holdings in Haleon, the Advil manufacturer formed in 2022 out of the former consumer-health divisions of Pfizer and GSK. In a two-part deal that could ...

The Haleon(LSE:HLN) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 4.1% organic sales growth in Q2 2024 and strategic product launches ...

GSK’s consumer health spinout Haleon has acquired exclusive US rights to commercialise the gel-based product, called MED3000, in return for an initial upfront payment of $4 million, milestone ...

Global healthcare firm Haleon has selected PubMatic as a supply partner to streamline its programmatic media buys. The goal is to enable Haleon to “make more informed, data-driven decisions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pfizer Inc. PFE has divested a $3.3 billion stake in Haleon HLN, reducing its holding in the British consumer healthcare company. What Happened: The transaction occurred on Monday, cutting Pfizer ...

(Reuters) -British consumer healthcare company Haleon said on Friday it has agreed to increase its stake in its Chinese joint venture to 88% from 55% for 4.47 billion yuan ($637.35 million).

Dr. Reddy’s Laboratories SA, Switzerland completed its acquisition of Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category outside of the United ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...